Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (591-600 of 1,095) with videos related to

Pageof 110
Sort By:
Immunotherapy|January 4, 2023
Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case reportVeronica Murianni, Luigi Cerbone, Pasquale Rescigno, et al.
Epilepsia|January 24, 2004
Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutationsPaolo Bonanni, Michela Malcarne, Francesca Moro, et al.
Intervirology|September 25, 2008
Genotyping of hepatitis B virus--genotypes a to g by multiplex polymerase chain reactionWen-Chun Liu, Magnus Lindh, Maria Buti, et al.
Frontiers in Oncology|December 13, 2021
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)Marco Maruzzo, Elena Verzoni, Maria Giuseppa Vitale, et al.
Biomedicines|August 26, 2022
Hashimoto's Thyroiditis Minimizes Lymph Node Metastasis in <i>BRAF</i> Mutant Papillary Thyroid CarcinomasPeter P Issa, Mahmoud Omar, Yusef Buti, et al.
Journal of Hepatology|November 1, 2011
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort studyJorg Petersen, Vlad Ratziu, Maria Buti, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 7, 2023
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancerMalvina Cremante, Silvia Puglisi, Annalice Gandini, et al.
Journal of Clinical and Translational Hepatology|November 16, 2022
ACE Score Identifies HBeAg-negative Inactive Carriers at a Single-point Evaluation, Regardless of HBV GenotypeLuisa Roade, Mar Riveiro-Barciela, Adriana Palom, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 19, 2023
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B studyAnna Feliu-Prius, Ana Barreira-Díaz, Ariadna Rando, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 14, 2015
Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatmentJavier Ampuero, José Antonio Del Campo, Lourdes Rojas, et al.
Pageof 110

Showing results (591-600 of 1,095) with videos related to

Sort By:
Pageof 110
Immunotherapy|January 4, 2023
Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case reportVeronica Murianni, Luigi Cerbone, Pasquale Rescigno, et al.
Epilepsia|January 24, 2004
Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutationsPaolo Bonanni, Michela Malcarne, Francesca Moro, et al.
Intervirology|September 25, 2008
Genotyping of hepatitis B virus--genotypes a to g by multiplex polymerase chain reactionWen-Chun Liu, Magnus Lindh, Maria Buti, et al.
Frontiers in Oncology|December 13, 2021
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)Marco Maruzzo, Elena Verzoni, Maria Giuseppa Vitale, et al.
Biomedicines|August 26, 2022
Hashimoto's Thyroiditis Minimizes Lymph Node Metastasis in <i>BRAF</i> Mutant Papillary Thyroid CarcinomasPeter P Issa, Mahmoud Omar, Yusef Buti, et al.
Journal of Hepatology|November 1, 2011
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort studyJorg Petersen, Vlad Ratziu, Maria Buti, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 7, 2023
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancerMalvina Cremante, Silvia Puglisi, Annalice Gandini, et al.
Journal of Clinical and Translational Hepatology|November 16, 2022
ACE Score Identifies HBeAg-negative Inactive Carriers at a Single-point Evaluation, Regardless of HBV GenotypeLuisa Roade, Mar Riveiro-Barciela, Adriana Palom, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 19, 2023
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B studyAnna Feliu-Prius, Ana Barreira-Díaz, Ariadna Rando, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 14, 2015
Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatmentJavier Ampuero, José Antonio Del Campo, Lourdes Rojas, et al.
Pageof 110